Paul has provided regulatory advice to Ventinova since 2010. As Regulatory Affairs Manager, he is responsible for securing market access in all target countries. With a master’s degree in electrical engineering and over 15 years in medical device development, Paul has secured market access for a number of manufacturers worldwide.
Paul: “With its lean processes and documentation structure, Ventinova is now very well equipped to handle the changing regulatory environment in an efficient manner.”
The CE mark of Evone in 2017. Well over 300 patient cases in 10 countries with Evone and Tritube. Distributors across Europe ready to demonstrate and sell Evone). The completion of four randomized controlled trials and one multi center observational study. The...